GalenusRx has filed a notice of an exempt offering of securities to raise $8,030,647.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, GalenusRx is raising up to $8,030,647.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jacques Turgeon played a key…